Trial intelligence / Profile preview

Platelet-rich plasma before frozen embryo transfer in women with repeated implantation failure

IRCT20160815029374N2Phase 2Completed

Sponsor
Vice chancellor of Mazandaran University of Medical Science.
Start
Sep 2017
Countries
1
01

Overview

Phase 2, randomised, open-label trial of platelet-rich plasma in Recurrent Implantation Failure (RIF) and female infertility (2 arms), sponsored by Vice chancellor of Mazandaran University of Medical Science. Primary endpoint: Clinical pregnancy rate. Started Sep 2017; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

Recurrent Implantation Failure (RIF)female infertility

Beyond the preview

Go deeper on IRCT20160815029374N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160815029374N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call